{
 "as_of": "2026-11-06",
 "cmr": "ca-cm-kg/CSE/BUX",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# BioMark Diagnostics Inc. (CSE: BUX) — research page\n\nAs of 2026-11-06 · ca-cm-kg · record version 1\n\n## Identity and listing\n\nBioMark Diagnostics Inc. is listed on the CSE under ticker BUX. The LEI is 529900UHZ378KKXOLY69; no ISIN is on the record. The security type is Corporate, the segment is not on the record, the sector is Life Sciences, and the jurisdiction is British Columbia (CA-BC). The listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 8 filings in the twelve months to 2026-11-06, all of them newswire releases, on 7 filing days. The median gap between filing days is 45.0 days. The latest filing is dated 2026-09-21, a newswire release, 46 days before the record date. The CSE median gap is 19.5 days across 724 issuers, and the CSE median latency is 17.0 days. The Life Sciences median gap is 17.5 days across 200 issuers, and the Life Sciences median latency is 14 days. The CSE median filing count is 6.0 and the Life Sciences median filing count is 7.0.\n\n## Auditor\n\nThe auditor of record is MNP LLP; its location is not on the record. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no listing, delisting, name change, domicile change or segment move lines. The halt flag is listed, not halted.\n\n## Orderability\n\nParagraph (o) of the definition is determinable and returns signal ACM-200. Paragraph (q) of the definition is determinable and returns signal ACM-200. The rule version is acm-68000/ca/kyp-know-your-product-ni-31-103/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nNo research house was found on the issuer's investor-relations pages. The count is 0.\n\n## Open research\n\nNo openly published research notes were found. The count is 0.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe issuer's years are not sealed; the issuer-years list is empty. The market's vintage is not sealed, and the market earliest sealed date is not on the record. The live record began 2026-09-10. The years 2021 through 2026 are sealed in the store but not served as of a date; the as-of door answers not_sealed.\n\n## Sources\n\n7 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://thecse.com/api/webapi/listed-companies/ (identity.exchange)\n- https://api.gleif.org/api/v1/lei-records/529900UHZ378KKXOLY69 (identity.jurisdiction)\n- https://mcp.ca-cm-kg.ai/events/CSE/BUX (the disclosure lines)\n- https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)\n- https://thecse.com/listings/biomark-diagnostics-inc/ (the auditor)\n- https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.ca-cm-kg.ai/record/CSE/BUX (the record)\n",
 "market": "CA",
 "node": "ca-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": "2026-09-10",
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "6 years are sealed in the CA store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false,
   "store_years_sealed_not_served": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ]
  },
  "auditor": {
   "auditor": {
    "read_by": "CSE",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://thecse.com/listings/biomark-diagnostics-inc/",
    "state": "confirmed",
    "value": "MNP LLP"
   },
   "auditor_firm_id": {
    "market": "CA",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "CA",
    "state": "not_on_record"
   },
   "changes": []
  },
  "cmr": "ca-cm-kg/CSE/BUX",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 724,
     "median_cadence_gap_days": 19.5,
     "median_filings": 6,
     "median_latency_days": 17,
     "name": "CSE"
    },
    "sector": {
     "issuers": 200,
     "median_cadence_gap_days": 17.5,
     "median_filings": 7,
     "median_latency_days": 14,
     "name": "Life Sciences"
    }
   },
   "by_type": {
    "newswire_release": 8
   },
   "cadence_median_gap_days": 45,
   "filing_days": 7,
   "filings": 8,
   "latency_days": 46,
   "latest": [
    {
     "category": null,
     "date": "2026-09-21",
     "source": "https://www.newsfilecorp.com/release/315081/BioMark-Announces-Participation-in-upcoming-MSACL-2026-and-BIOHorizon-2026-Life-Sciences-Conferences?lang=fr",
     "title": "BioMark Announces Participation in upcoming MSACL 2026 and BIOHorizon 2026 Life Sciences Conferences",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-09-21",
     "source": "https://www.newsfilecorp.com/release/315081/BioMark-Announces-Participation-in-upcoming-MSACL-2026-and-BIOHorizon-2026-Life-Sciences-Conferences",
     "title": "BioMark Announces Participation in upcoming MSACL 2026 and BIOHorizon 2026 Life Sciences Conferences",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-07-31",
     "source": "https://www.newsfilecorp.com/release/307371/BioMark-Diagnostics-Endorses-Global-Call-for-Equitable-Access-to-Early-Screening-on-2026-World-Lung-Cancer-Day",
     "title": "BioMark Diagnostics Endorses Global Call for Equitable Access to Early Screening on 2026 World Lung Cancer Day",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-06-23",
     "source": "https://www.newsfilecorp.com/release/302429/BioMark-Diagnostics-Secures-Landmark-Canadian-and-European-Patent-Allowances-for-EarlyStage-Lung-Cancer-Blood-Test",
     "title": "BioMark Diagnostics Secures Landmark Canadian and European Patent Allowances for Early-Stage Lung Cancer Blood Test",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-04-14",
     "source": "https://www.newsfilecorp.com/release/292291/BioMark-Diagnostics-to-Present-Liquid-Biopsy-Platform-at-the-Canadian-Thoracic-Society-Research-Forum",
     "title": "BioMark Diagnostics to Present Liquid Biopsy Platform at the ...",
     "type": "newswire_release"
    }
   ],
   "latest_filing_date": "2026-09-21",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.ca-cm-kg.ai/events/CSE/BUX",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "thecse.com listed-companies API (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://thecse.com/api/webapi/listed-companies/",
    "state": "sourced",
    "value": "CSE"
   },
   "isin": {
    "market": "CA",
    "reason": "no ISIN found on issuer pages",
    "state": "not_on_record"
   },
   "jurisdiction": {
    "read_by": "GLEIF LEI record (LEI per the LEI column)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.gleif.org/api/v1/lei-records/529900UHZ378KKXOLY69",
    "state": "sourced",
    "value": "British Columbia (CA-BC)"
   },
   "lei": {
    "read_by": "GLEIF name-exact",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.gleif.org/api/v1/lei-records/529900UHZ378KKXOLY69",
    "state": "sourced",
    "value": "529900UHZ378KKXOLY69"
   },
   "name": {
    "read_by": "thecse.com listed-companies API (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://thecse.com/api/webapi/listed-companies/",
    "state": "sourced",
    "value": "BioMark Diagnostics Inc."
   },
   "sector": {
    "read_by": "thecse.com listed-companies API (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://thecse.com/api/webapi/listed-companies/",
    "state": "sourced",
    "value": "Life Sciences"
   },
   "security_type": {
    "read_by": "thecse.com listed-companies API (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://thecse.com/api/webapi/listed-companies/",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "CA",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "thecse.com listed-companies API (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://thecse.com/api/webapi/listed-companies/",
    "state": "sourced",
    "value": "BUX"
   },
   "website": {
    "market": "CA",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": [],
   "listing": [],
   "name_change": [],
   "segment_move": []
  },
  "market": "CA",
  "node": "ca-cm-kg",
  "numbers_hash": "sha256:a92ac2aa4b7ea64b0bb7991593318b0554ef7438dee5d415609d0088d6a67ae8",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "Paragraph (o) of the definition",
    "Paragraph (q) of the definition"
   ],
   "outcomes": {
    "Paragraph (o) of the definition": {
     "determinable": true,
     "signal": "ACM-200"
    },
    "Paragraph (q) of the definition": {
     "determinable": true,
     "signal": "ACM-200"
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.ca-cm-kg.ai/book/aio.json",
    "door": "https://mcp.ca-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/ca/kyp-know-your-product-ni-31-103/r1",
   "section": "ca.aio.v11"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.ca-cm-kg.ai/record/CSE/BUX",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:a92ac2aa4b7ea64b0bb7991593318b0554ef7438dee5d415609d0088d6a67ae8",
 "path": "/ca/CSE/BUX",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "BioMark Diagnostics Inc. is listed on the CSE under ticker BUX. The LEI is 529900UHZ378KKXOLY69; no ISIN is on the record. The security type is Corporate, the segment is not on the record, the sector is Life Sciences, and the jurisdiction is British Columbia (CA-BC). The listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 8 filings in the twelve months to 2026-11-06, all of them newswire releases, on 7 filing days. The median gap between filing days is 45.0 days. The latest filing is dated 2026-09-21, a newswire release, 46 days before the record date. The CSE median gap is 19.5 days across 724 issuers, and the CSE median latency is 17.0 days. The Life Sciences median gap is 17.5 days across 200 issuers, and the Life Sciences median latency is 14 days. The CSE median filing count is 6.0 and the Life Sciences median filing count is 7.0.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is MNP LLP; its location is not on the record. The record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds no listing, delisting, name change, domicile change or segment move lines. The halt flag is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "Paragraph (o) of the definition is determinable and returns signal ACM-200. Paragraph (q) of the definition is determinable and returns signal ACM-200. The rule version is acm-68000/ca/kyp-know-your-product-ni-31-103/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research house was found on the issuer's investor-relations pages. The count is 0.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found. The count is 0.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The issuer's years are not sealed; the issuer-years list is empty. The market's vintage is not sealed, and the market earliest sealed date is not on the record. The live record began 2026-09-10. The years 2021 through 2026 are sealed in the store but not served as of a date; the as-of door answers not_sealed.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "7 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://thecse.com/api/webapi/listed-companies/"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://api.gleif.org/api/v1/lei-records/529900UHZ378KKXOLY69"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.ca-cm-kg.ai/events/CSE/BUX"
  },
  {
   "for": "the halt flag",
   "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100"
  },
  {
   "for": "the auditor",
   "source": "https://thecse.com/listings/biomark-diagnostics-inc/"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.ca-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.ca-cm-kg.ai/record/CSE/BUX"
  }
 ],
 "title": "BioMark Diagnostics Inc. (BUX) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}